ARTICLE | Company News
GenPat77, Medarex deal
August 28, 2006 7:00 AM UTC
MEDX will use its UltiMab Human Antibody Development System to generate antibodies against autoimmune disease targets from GenPat77. The companies will share product development and commercialization ...